Elizabeth Hougen
Finanzdirektor/CFO bei IONIS PHARMACEUTICALS, INC.
Vermögen: 4 Mio $ am 30.04.2024
Profil
Derzeit ist Elizabeth L. Hougen Chief Financial Officer & SVP-Finance bei Ionis Pharmaceuticals, Inc. und Treasurer & Director bei Akcea Therapeutics, Inc. (eine Tochtergesellschaft von Ionis Pharmaceuticals, Inc.). In der Vergangenheit hatte Frau Hougen die Position des Chief Financial Officer & Executive Director bei Molecular Biosystems, Inc. und CFO & Principal Accounting Officer bei Akcea Therapeutics, Inc. inne. Frau Hougen erhielt einen MBA von der University of San Diego und einen Bachelor-Abschluss vom Franklin & Marshall College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2024 | 92 905 ( 0,06% ) | 4 Mio $ | 30.04.2024 |
Aktive Positionen von Elizabeth Hougen
| Unternehmen | Position | Beginn |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.05.2000 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 19.05.2021 |
Ehemalige bekannte Positionen von Elizabeth Hougen
| Unternehmen | Position | Ende |
|---|---|---|
| AKCEA THERAPEUTICS, INC. | Finanzdirektor/CFO | 31.08.2017 |
Molecular Biosystems, Inc.
 Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Finanzdirektor/CFO | 01.01.2000 |
| AKCEA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Elizabeth Hougen
| University of San Diego | Masters Business Admin |
| Franklin & Marshall College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Health Technology |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
